Prostate Specific Antigen (PSA) Testing Market Analysis Report & Forecast to 2028 - Competitors, Revenue, Market Trends, Share, Size, Growth and Opportunities
The Global and United States Prostate Specific Antigen (PSA) Testing Market Report was published by QYResearch recently.
Global Prostate Specific Antigen (PSA) Testing Scope and Market Size
Prostate Specific Antigen (PSA) Testing market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Prostate Specific Antigen (PSA) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Prostate Specific Antigen (PSA) Testing market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Full Report Description, Table of Figure, Chart, Free sample, etc. please
https://us.qyresearch.com/reports/343683/prostate-specific-antigen-psa-testing
Segment by Type
Radioimmunoassay
Enzyme Immunoassay
Segment by Application
Hospitals
Clinics
Diagnostic Centers
Research Institute
Others
The report on the Prostate Specific Antigen (PSA) Testing market covers the following region analysis:
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
The report mentions the prominent market player consisting of:
Cleveland Diagnostics
Abbott
Siemens Healthineers
DiaSorin
Roche Holding AG
Beckman Coulter
Mediwatch(LABORIE)
Boditech
Bristol Myers Squibb
GE Healthcare
Endocare
GlaxoSmith Kline
Anixa Biosciences
Ortho Clinical
Fujirebio
Merck
Key Objectives of This Report
To study and analyze the global Prostate Specific Antigen (PSA) Testing consumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.
To understand the structure of Prostate Specific Antigen (PSA) Testing market by identifying its various subsegments.
Focuses on the key global Prostate Specific Antigen (PSA) Testing manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Prostate Specific Antigen (PSA) Testing with respect to individual growth trends, prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).
To project the consumption of Prostate Specific Antigen (PSA) Testing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Key Topics Covered
1 Study Coverage
2 Market by Type
3 Market by Application
4 Global Prostate Specific Antigen (PSA) Testing Competitor Landscape by Company
5 Global Prostate Specific Antigen (PSA) Testing Market Size by Region
5.1 Global Prostate Specific Antigen (PSA) Testing Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Prostate Specific Antigen (PSA) Testing Market Size in Volume by Region (2017-2028)
5.2.1 Global Prostate Specific Antigen (PSA) Testing Sales in Volume by Region: 2017-2022
5.2.2 Global Prostate Specific Antigen (PSA) Testing ales in Volume Forecast by Region (2023-2028)
5.3 Global Prostate Specific Antigen (PSA) Testing Market Size in Value by Region (2017-2028)
5.3.1 Global Prostate Specific Antigen (PSA) Testing Sales in Value by Region: 2017-2022
5.3.2 Global Prostate Specific Antigen (PSA) Testing Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Prostate Specific Antigen (PSA) Testing Market Size YoY Growth 2017-2028
6.1.2 North America Prostate Specific Antigen (PSA) Testing Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Prostate Specific Antigen (PSA) Testing Market Size YoY Growth 2017-2028
6.3.2 Europe Prostate Specific Antigen (PSA) Testing Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Prostate Specific Antigen (PSA) Testing Market Size YoY Growth 2017-2028
6.4.2 Latin America Prostate Specific Antigen (PSA) Testing Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.4.6 Colombia
6.5 Middle East and Africa
6.5.1 Middle East and Africa Prostate Specific Antigen (PSA) Testing Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Prostate Specific Antigen (PSA) Testing Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Cleveland Diagnostics
7.1.1 Cleveland Diagnostics Company Details
7.1.2 Cleveland Diagnostics Business Overview
7.1.3 Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Introduction
7.1.4 Cleveland Diagnostics Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
7.1.5 Cleveland Diagnostics Recent Development
7.2 Abbott
7.2.1 Abbott Company Details
7.2.2 Abbott Business Overview
7.2.3 Abbott Prostate Specific Antigen (PSA) Testing Introduction
7.2.4 Abbott Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
7.2.5 Abbott Recent Development
7.3 Siemens Healthineers
7.3.1 Siemens Healthineers Company Details
7.3.2 Siemens Healthineers Business Overview
7.3.3 Siemens Healthineers Prostate Specific Antigen (PSA) Testing Introduction
7.3.4 Siemens Healthineers Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
7.3.5 Siemens Healthineers Recent Development
7.4 DiaSorin
7.4.1 DiaSorin Company Details
7.4.2 DiaSorin Business Overview
7.4.3 DiaSorin Prostate Specific Antigen (PSA) Testing Introduction
7.4.4 DiaSorin Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
7.4.5 DiaSorin Recent Development
7.5 Roche Holding AG
7.5.1 Roche Holding AG Company Details
7.5.2 Roche Holding AG Business Overview
7.5.3 Roche Holding AG Prostate Specific Antigen (PSA) Testing Introduction
7.5.4 Roche Holding AG Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
7.5.5 Roche Holding AG Recent Development
7.6 Beckman Coulter
7.6.1 Beckman Coulter Company Details
7.6.2 Beckman Coulter Business Overview
7.6.3 Beckman Coulter Prostate Specific Antigen (PSA) Testing Introduction
7.6.4 Beckman Coulter Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
7.6.5 Beckman Coulter Recent Development
7.7 Mediwatch(LABORIE)
7.7.1 Mediwatch(LABORIE) Company Details
7.7.2 Mediwatch(LABORIE) Business Overview
7.7.3 Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Introduction
7.7.4 Mediwatch(LABORIE) Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
7.7.5 Mediwatch(LABORIE) Recent Development
7.8 Boditech
7.8.1 Boditech Company Details
7.8.2 Boditech Business Overview
7.8.3 Boditech Prostate Specific Antigen (PSA) Testing Introduction
7.8.4 Boditech Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
7.8.5 Boditech Recent Development
7.9 Bristol Myers Squibb
7.9.1 Bristol Myers Squibb Company Details
7.9.2 Bristol Myers Squibb Business Overview
7.9.3 Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Introduction
7.9.4 Bristol Myers Squibb Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
7.9.5 Bristol Myers Squibb Recent Development
7.10 GE Healthcare
7.10.1 GE Healthcare Company Details
7.10.2 GE Healthcare Business Overview
7.10.3 GE Healthcare Prostate Specific Antigen (PSA) Testing Introduction
7.10.4 GE Healthcare Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
7.10.5 GE Healthcare Recent Development
7.11 Endocare
7.11.1 Endocare Company Details
7.11.2 Endocare Business Overview
7.11.3 Endocare Prostate Specific Antigen (PSA) Testing Introduction
7.11.4 Endocare Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
7.11.5 Endocare Recent Development
7.12 GlaxoSmith Kline
7.12.1 GlaxoSmith Kline Company Details
7.12.2 GlaxoSmith Kline Business Overview
7.12.3 GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Introduction
7.12.4 GlaxoSmith Kline Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
7.12.5 GlaxoSmith Kline Recent Development
7.13 Anixa Biosciences
7.13.1 Anixa Biosciences Company Details
7.13.2 Anixa Biosciences Business Overview
7.13.3 Anixa Biosciences Prostate Specific Antigen (PSA) Testing Introduction
7.13.4 Anixa Biosciences Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
7.13.5 Anixa Biosciences Recent Development
7.14 Ortho Clinical
7.14.1 Ortho Clinical Company Details
7.14.2 Ortho Clinical Business Overview
7.14.3 Ortho Clinical Prostate Specific Antigen (PSA) Testing Introduction
7.14.4 Ortho Clinical Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
7.14.5 Ortho Clinical Recent Development
7.15 Fujirebio
7.15.1 Fujirebio Company Details
7.15.2 Fujirebio Business Overview
7.15.3 Fujirebio Prostate Specific Antigen (PSA) Testing Introduction
7.15.4 Fujirebio Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
7.15.5 Fujirebio Recent Development
7.16 Merck
7.16.1 Merck Company Details
7.16.2 Merck Business Overview
7.16.3 Merck Prostate Specific Antigen (PSA) Testing Introduction
7.16.4 Merck Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
7.16.5 Merck Recent Development
- Industry Chain and Sales Channels Analysis
8.1 Near-infrared Brain Imaging SystemsIndustry Chain Analysis
8.2 Near-infrared Brain Imaging SystemsKey Raw Materials
8.2.1 Key Raw Materials
8.2.2 Near-infrared Brain Imaging SystemsDistributors
8.3 Near-infrared Brain Imaging SystemsProduction Mode & Process
8.4 Near-infrared Brain Imaging SystemsSales and Marketing
8.4.1 Near-infrared Brain Imaging SystemsSales Channels
8.4.2 Near-infrared Brain Imaging SystemsDistributors
8.5 Near-infrared Brain Imaging SystemsCustomers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Any questions or further requirements about the report, please enter：
https://us.qyresearch.com/reports/343683/prostate-specific-antigen-psa-testing
Company Profiles:
QYResearch founded in California, USA in 2007. It is a leading global market research and consulting company. With over 15 years’ experience and professional research team in various cities over the world, QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let’s work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com